Follitropin alfa biosimilar (Alapharmab)

促卵泡激素α生物类似药(康宁杰瑞)

Report date: 2026/05/20 20:02:01

Base Information

Drug NameFollitropin alfa biosimilar (Alapharmab)
Drug Alias Name促卵泡激素α生物仿制药(康宁杰瑞)重组人促卵泡激素注射液LM-001
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionFollicle-stimulating hormone receptor agonists
TargetsFollicle-stimulating hormone receptor
Therapy Area/IndicationsInfertility, FemaleInfertility
Global Approved IndicationsInfertility
Approved Indications in ChinaInfertility
Original Approved Country/TerritoryMainland China
Original Approved Date2025/11/25
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSuzhou Alphamab Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAlphamab Jilin Co Ltd
Inactive CompaniesN/A
Active IndicationsInfertility
Inactive IndicationsInfertility, Female

Other Information

ATC CodeG03GA06
Related LinksN/A